Navigation Links
FDA Decision Encourages Lamictal Generics

As the FDA cannot approve an abbreviated new drug application (ANDA) for a listed drug that has been withdrawn due to reasons of safety or efficacy// , the agency had to determine the reasons for the withdrawal before approving any generic version.

The investigation found no evidence of safety or efficacy issues, and the FDA has announced that it can approve ANDAs provided all other legal and regulatory requirements are met. The FDA added that the ruling was in response to a citizen's petition from a patent attorney that was filed in June 1995.

However, even if rival drug makers were to file an application for the drug, the respective company could still face a patent suit from Glaxo as the patent in the US is not due to run out until 2009. Lamictal already faces generic competition in Europe, where its patents have expired.

Lamictal (lamotrigine) is an antiepileptic drug indicated as adjunctive therapy for partial seizures in adults and pediatric patients. It is also approved for conversion to monotherapy in adults with partial seizures who are receiving treatment with a single enzyme-inducing antiepileptic drug or valproate. In addition, Lamictal is indicated for the maintenance treatment of bipolar I disorder in certain patients.

Source-Bio-Bio Technology
'"/>




Page: 1

Related medicine news :

1. Decision making made easier
2. Decision making made easier
3. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
4. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
5. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
6. HRT: A Difficult Decision
7. Decisions On End-of-Life Treatment Found To Vary From Country To Country
8. Pharma Companies May Influence The Decisions Of Medical Students
9. Critical Decisions Have To Be Taken By Mothers Of Premature Babies
10. Novel Study Unravels a New Dimension to Decision Making
11. Distinct Brain Sections Are Activated While Making Risky Decisions

Post Your Comments:
(Date:12/1/2009)...jor Peer Review Journals Have Identified The PADDS... The Evidence-Based Assessment Of Attention And Ex... Recent Are Listed Below. , ...Leesa V. Huang Ph.D. for the Journal of Attention...e synopsis of this article is available on PubMed...
(Date:12/1/2009)...RNewswire/ -- To date, hospitals have not found a ... the $20 cost of the disposable sensor for your br...nesthesiologists have not told hospitals how impor...from routine anesthesia over-medication. ,, Ane...cation, message from their leaders because their o...
(Date:12/1/2009)...ography screening may increase breast cancer risk ...o breast cancer, according to a study presented to...ety of North America (RSNA). , "For women at hi...tant, but a careful approach should be taken when ... particularly under age 30," said Marijke C. Janse...
(Date:12/1/2009)...ead to early degeneration in the spine, according ...f the Radiological Society of North America (RSNA)...ion between increased body mass index (BMI) and di...ad author, Judah G. Burns, M.D., fellow in diagnos...ontefiore in New York City. , In this retrospec...
(Date:11/30/2009)...sults of a randomized, controlled clinical trial p...ogical Society of North America (RSNA) reveal that...n arteries that supply blood to the legs and other...t coronary artery disease. ,, Peripheral arter...n of fat, cholesterol and other substances, builds...
Breaking Medicine News(10 mins):Health News:Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV 2Health News:Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV 3Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2Health News:Mammography may increase breast cancer risk in some high-risk women 2Health News:Overweight children may develop back pain and spinal abnormalities 2Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 2Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 3
...s olanzapine, quetiapine may also lower ,good, cho...pril 15 (HealthDay News) Newer antipsychotic drug...od") cholesterol in Alzheimer,s patients, accordin...ition, patients who took olanzapine experienced in...
... Portal offers expanded career and r...glewood, CO (PRWEB) April 15, 2009 -- HEALTHeCARE...s online career centers of more than 70 profession...an 1,500 cardiology professionals, greater than 20...
...ndicates there is room for further education among...eleased today from Independence Blue Cross (IBC) s...ductible health plans (HDHPs) --- which feature lo... care options, such as generics versus brand drugs...
... April 15 /PRNewswire-FirstCall/ - Medifocus Inc. ...s when using the Company,s proprietary focused hea...early stage breast cancer tumors, were presented d...Center Conference held March 14-18, 2009 in Las Ve...
...S, April 15 Over the past two months, staff membe...g along with contracted vendors and service provid...a senior" by participating in a series of hands-on...nd focused on providing participants, the opportun...
...N, April 15, 2009 News media covering the chemica...s are invited to join an American Chemical Society...echnology commercialization in lean times. , Sc... and Technology Management and the GlaxoSmithKline...
Other Medicine News:Health News:Newer Antipsychotics May Boost Weight in Alzheimer's Patients 2Health News:Cardiology Career Network Launches Within HEALTHeCAREERS Network 2Health News:Study Shows Consumers With High Deductible Health Plans Are More Savvy About Controlling Costs, Improving Health 2Health News:Study Shows Consumers With High Deductible Health Plans Are More Savvy About Controlling Costs, Improving Health 3Health News:Study Shows Consumers With High Deductible Health Plans Are More Savvy About Controlling Costs, Improving Health 4Health News:Study Shows Consumers With High Deductible Health Plans Are More Savvy About Controlling Costs, Improving Health 5Health News:Medifocus Inc. Reports Improved Clinical Efficacy for its Phase II, Randomized Clinical Study for the Treatment of Early Stage Breast Cancer Tumors 2Health News:Medifocus Inc. Reports Improved Clinical Efficacy for its Phase II, Randomized Clinical Study for the Treatment of Early Stage Breast Cancer Tumors 3Health News:SCAN Health Plan Provides 'Senior Sensitivity Training' to City of Los Angeles Department of Aging and Network Service Providers 2Health News:SCAN Health Plan Provides 'Senior Sensitivity Training' to City of Los Angeles Department of Aging and Network Service Providers 3Health News:Media invited to ACS Webinar on chemistry and entreprenuership and small/medium business 2
(Date:11/30/2009)...swire/ -- Reportlinker.com announces that a new ma...: ,, Europe Ophthalmic Devices Investment Oppo...http://www.reportlinker.com/p0166515/Europe-Ophtha...-Forecasts-to-2015.html ,, Europe Ophthalmic D...casts to 2015 ,, Summary ,, This report is...
(Date:11/30/2009)...ewswire/ -- StemCyte, Inc. concluded an exclusive ...mia Sinica, the National Laboratory of Taiwan, for...erty (IP) related to the treatment of Chronic Stro...red by a team led by Professor John Lin, MD, PhD a...urrently the exclusive collaborator with StemCyte ...
(Date:11/30/2009)...30 eHealthSource.com launched the ...o products approved for Flexible Spending Account ...ite is also the first to exclusively carry value-b...s up to 75 percent on everyday healthcare needs. ...are headaches - high costs and complexity," says e...
Breaking Medicine Technology:Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 2Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 3Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 4Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 5Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 6Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 7Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 8Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 9Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 10Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 11Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 12Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 13Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 14Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 15Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 16StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2Gain Entry to the Closed 2009 Chicago Marathon by Joining Susan G Komens Marathon for the Cure 28R 29 48393 1Gain Entry to the Closed 2009 Chicago Marathon by Joining Susan G Komens Marathon for the Cure 28R 29 48393 2University of Texas Picosatellite to be launched from space shuttle to begin milestone mission 12548 1University of Texas Picosatellite to be launched from space shuttle to begin milestone mission 12548 2University of Texas Picosatellite to be launched from space shuttle to begin milestone mission 12548 3First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products 48391 1First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products 48391 2First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products 48391 3First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products 48391 4First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products 48391 5
...to be presented at NACFC and ICAAC/IDSA meetings t...s, Inc. today,announced additional clinical and pr... formulation of levofloxacin inhaled solution deli... for use in cystic fibrosis (CF),and chronic obstr...show,that aerosol dosing of MP-376 was well tolera...
...ct. 22 Congresswoman Debbie,Wasserman Schultz wil...ity,and the U.S. Department of Defense to support ... Biology Professor Jeffery Alan Plunkett - a leade...University President Monsignor,Franklyn M. Casale ...rsity,science programs - including financial aid o...
Other Medicine Technology:Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 2Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 3Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 4Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 5Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 6
VasoSeal VHD KIT 4
...cal Hemostats First Stop absorbable collagen hemos... that offers superior handling and removal charact...d to fit the wound. FirstStop products are not dis...r hemostasis is achieved. As the collagen forms a ...
Hemacarotid Knitted
Vasoseal Low Profile kit 4
Medicine Products: